These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32116510)

  • 1. Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson's Disease and Related Diseases.
    Sun Y; Guo C; Yuan L; Li W; Wang ZY; Yue F; Li JY
    Front Neurosci; 2020; 14():63. PubMed ID: 32116510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
    Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet amyloid polypeptide triggers α-synuclein pathology in Parkinson's disease.
    Meng L; Li Y; Liu C; Zhang G; Chen J; Xiong M; Pan L; Zhang X; Chen G; Xiong J; Liu C; Xu X; Bu L; Zhang Z; Zhang Z
    Prog Neurobiol; 2023 Jul; 226():102462. PubMed ID: 37150314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model.
    Lv YQ; Yuan L; Sun Y; Dou HW; Su JH; Hou ZP; Li JY; Li W
    Transl Neurodegener; 2022 Mar; 11(1):14. PubMed ID: 35255986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transactive DNA Binding Protein 43 Rather Than Other Misfolded Proteins in the Brain is Associated with Islet Amyloid Polypeptide in Pancreas in Aged Subjects with Diabetes Mellitus.
    Leino M; Popova SN; Alafuzoff I
    J Alzheimers Dis; 2017; 59(1):43-56. PubMed ID: 28582864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated α-Synuclein Accumulations and Lewy Body-like Pathology Distributed in Parkinson's Disease-Related Brain Areas of Aged Rhesus Monkeys Treated with MPTP.
    Huang B; Wu S; Wang Z; Ge L; Rizak JD; Wu J; Li J; Xu L; Lv L; Yin Y; Hu X; Li H
    Neuroscience; 2018 May; 379():302-315. PubMed ID: 29592843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranes as modulators of amyloid protein misfolding and target of toxicity.
    Rawat A; Langen R; Varkey J
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1863-1875. PubMed ID: 29702073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112.
    Klegeris A; McGeer PL
    Biochem Biophys Res Commun; 2007 Jun; 357(4):1096-9. PubMed ID: 17459337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
    Horvath I; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12473-12477. PubMed ID: 27791129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of α-Synuclein Pathology in PINK1 Knockout Rat Brains.
    Creed RB; Goldberg MS
    Front Neurosci; 2018; 12():1034. PubMed ID: 30686993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein receptor-related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson's disease.
    Luo H; Peng C; Wu C; Liu C; Li Q; Yu S; Liu J; Chen M
    Neural Regen Res; 2024 Jul; ():. PubMed ID: 39104172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
    Jeong HR; An SS
    Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.
    Gündner AL; Duran-Pacheco G; Zimmermann S; Ruf I; Moors T; Baumann K; Jagasia R; van de Berg WDJ; Kremer T
    Neurobiol Dis; 2019 Jan; 121():205-213. PubMed ID: 30236861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum albumin impedes the amyloid aggregation and hemolysis of human islet amyloid polypeptide and alpha synuclein.
    Kakinen A; Javed I; Faridi A; Davis TP; Ke PC
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1803-1809. PubMed ID: 29366673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
    Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
    Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo.
    Mo XD; Gao LP; Wang QJ; Yin J; Jing YH
    Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease.
    Chu Y; Goldman JG; Kelly L; He Y; Waliczek T; Kordower JH
    Neurobiol Dis; 2014 Sep; 69():1-14. PubMed ID: 24825319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.